Not yet taking people in Franciaország1. fázis
A first-in-human, open-label, clinical study to assess the safety, tolerability, and activity of OT-C001 (amplified/activated allogenic natural killer cells) in patients with relapsed/refractory diffuse large B-cell lymphoma
Key facts
- Where
- Montpellier Cedex 05 és Toulouse Cedex 9, FranciaországSee the 2 sites
- Phase
- 1. fázis
Where in Franciaország
- CHU de MontpellierMontpellier Cedex 05, FranciaországToborzás még nem indult
- Oncopole Claudius RegaudToulouse Cedex 9, FranciaországToborzás még nem indult
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Emercell SAS
- Trial code
- EU 2024-511843-24-00
- Record updated
- 2026. november 6.